Limited T-cell repertoire in renal allograft and allogeneic melanoma transmitted by the graft

Transplantation

Volumn 64, Issue 11, 1997, Pages 1627-1630

  Barth, Claudia ^a   Stachowski, Jozef ^a   Von Menges, Albrecht ^a   Rodermann, Ernst ^a   Pollok, Manfred ^a   Smola, Hans ^a   Krieg, Thomas ^a   Baldamus, Conrad A ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; GRANZYME B; HLA ANTIGEN; IMMUNOSUPPRESSIVE AGENT; OKT 3; PERFORIN; PREDNISONE; RECOMBINANT GAMMA INTERFERON; RECOMBINANT INTERLEUKIN 2; TUMOR ANTIGEN;

ADULT; ARTICLE; CASE REPORT; DRUG WITHDRAWAL; FEMALE; HLA SYSTEM; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY ALLOGRAFT; KIDNEY GRAFT REJECTION; MELANOMA; MONONUCLEAR CELL; PRIORITY JOURNAL; SKIN NODULE; T LYMPHOCYTE; TUMOR REJECTION;

AGED; FEMALE; GRANZYMES; HISTOCOMPATIBILITY TESTING; HUMANS; KIDNEY TRANSPLANTATION; MELANOMA; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PORE FORMING CYTOTOXIC PROTEINS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RETROSPECTIVE STUDIES; SERINE ENDOPEPTIDASES; T-LYMPHOCYTES; TRANSPLANTATION IMMUNOLOGY;

EID: 0031443436     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199712150-00026     Document Type: Article

References (29)

1. Penn I. Donor transmitted disease: cancer. Transplant Proc 1991; 23: 2629.
2. Conlon PJ, Smith SR. Transmission of cancer with cadaveric donor organs. J Am Soc Nephrol 1995; 6: 54.
3. Homburg A, Kindler J, Hofstaedter F, Klose KC, Recker F. Regression of an adenocarcinoma transmitted by a cadaver kidney graft. Transplantation 1988; 46: 777.
4. Cherqui D, Duvoux C, Plassa F, et al. Lymphoproliferative disorder of donor origin in a liver transplant recipient: complete remission after drastic reduction of immunosuppression without graft loss. Transplantation 1993; 56: 1023.
5. Shirwan H, Chi D, Makowa L, Cramer DV. Lymphocytes infiltrating rat cardiac allografts express a limited repertoire of T cell receptor Vβ genes. J Immunol 1993; 151: 5228.
6. Barth C, Pavlakis M, Lavery P, Strom TB, Loertscher R. Restricted TCR Vβ repertoire in the human mixed lymphocyte reaction is determined by the TCR on the responder cell and not by the stimulating antigen on the stimulator cell. Transplantation 1996; 61: 133.
7. Barth C, von Menges A, Zanker B, Stachowski J, Lammerding P, Baldamus CA. Restricted T-cell repertoire in renal allografts during acute and chronic rejection. Kidney Int 1996; 50: 2020.
8. Datema G, Vaessen LMB, Daane RC, et al. Functional and molecular characterization of graft-infiltrating T lymphocytes propagated from different biopsies derived from one heart transplant patient. Transplantation 1994; 57: 1119.
9. Shilyansky J, Nishimura MI, Yannelli JR, et al. T-cell receptor usage by melanoma-specific clonal and highly oligoclonal tumor-infiltrating lymphocyte lines. Proc Natl Acad Sci USA 1994; 91: 2829.
10. Straten PT, Becker JC, Seremet T, Bröcker EB, Zeuthen J. Clonal T cell responses in tumor infiltrating lymphocytes from both regressive and progressive regions of primary human malignant melanomas. J Clin Invest 1996; 97: 279.
11. Morita T, Salmeron MA, Mosert RP, Ross MI, Itoh K. Oligoclonal expansion of Vβ8 cells in interleukin-2-activated T cells residing in subcutaneous metastatic melanoma. Clin Exp Metastasis 1992; 10: 69.
12. Weidmann E, Elder EM, Trucco M, Lotze MT, Whiteside TL. Usage of T-cell receptor Vβ chain genes in fresh and cultured tumor-infiltrating lymphocytes from human melanoma. Int J Cancer 1993; 54: 383.
13. Kubo H, Abe J, Obata F, et al. Dual recognition of a human cytotoxic T-cell clone for melanoma antigens. Cancer Res 1996; 56: 2368.
14. Traversari C, van der Bruggen P, Luescher IF, et al. A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J Exp Med 1992; 176: 1453.
15. Slingluff CL, Cox AL, Henderson RA, Hunt DF, Engelhard VH. Recognition of human melanoma cells by HLA-A2.1-restricted cytotoxic T lymphocytes is mediated by at least six shared peptide epitopes. J Immunol 1993; 150: 2955.
16. Kawakami Y, Eliyahu S, Delgado CH, et al. Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc Natl Acad Sci USA 1994; 91: 6458.
17. Lipman ML, Stevens AC, Strom TB. Heightened intragraft CTL gene expression in acutely rejecting renal allografts. J Immunol 1994; 152: 5120.
18. Hand SL, Alter MD, Finn OJ. T cell receptor β-chain repertoires are nonrandomly selected in responses to HLA-DR1. Transplantation 1996; 61: 1084.
19. Salvi S, Segalla F, Rao S, et al. Overexpression of the T-cell receptor β-chain variable region TCRBV14 in HLA-A2-matched primary human melanoma. Cancer Res 1995; 55: 3374.
20. Sensi M, Traversari C, Radrizzani M, et al. Cytotoxic T-lymphocyte clones from different patients display limited T-cell-receptor variable region gene usage in HLA-A2-restricted recognition of the melanoma antigen Melan-A/MART-1. Proc Natl Acad Sci USA 1995; 92: 5674.
21. Cole DJ, Weil DP, Shilansky J, et al. Characterization of the functional specificity of a cloned T-cell receptor heterodimer recognizing the MART-1 melanoma antigen. Cancer Res 1995; 55: 748.
22. Seito D, Morita T, Masuoka K, Maeda T, Saya H, Itoh K. Polyclonal uses of the T-cell receptor (TCR) alpha and beta genes for cytotoxic T lymphocytes in human metastatic melanoma: possible involvement of TCR alpha in tumor-cell recognition. Int J Cancer 1994; 58: 497.
23. Shi L, Mai S, Israels S, Browne K, Trapani JA, Greenberg AH. Granzyme B autonomously crosses the cell membrane and perform initiates apoptosis and GraB nuclear localization. J Exp Med 1997; 185: 855.
24. Strehlau J, Pavlakis M, Lipman M, et al. Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation. Proc Natl Acad Sci USA 1997; 94: 695.
25. Hahne H, Rimoldi D, Schroeter M, et al. Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape. Science 1996; 274: 1363.
26. Lu P, Garcia-Sanz JA, Lichtenheld MG, Podack ER. Perform expression in human peripheral blood mononuclear cells. J Immunol 1992; 148: 3354.
27. Latinis KM, Carr LL, Peterson EJ, Norian LA, Eliason SL, Koretzky GA. Regulation of CD95 (Fas) ligand expression by TCR-mediated signaling events. J Immunol 1997; 158: 4602.
28. Kurt RA, Park JA, Panelli MC, Schluter SF, Marchalonis JJ, Carolus B, Akporiaye ET. T lymphocytes infiltrating sites of tumor rejection and progression display identical Vβ usage but different cytotoxic activities. J Immunol 1995; 154: 3969.
29. Leger-Ravet MB, Mathiot C, Portier A, et al. Increased expression of perform and granzyme B genes in patients with metastatic melanoma treated with recombinant interleukin-2. Cancer Immunol Immunother 1994; 39: 53.